Mount Sinai Health System · 2 weeks ago
Post Doctoral Fellow-MSH-12903-004
New York, NY
Full-time
Onsite
New Grad, Entry Level
$72K/yr - $80K/yrMount Sinai Health System is one of the largest academic medical systems in the New York metro area, and they are seeking a Post Doctoral Fellow in the Division of Gastroenterology. The main objective of this role is to identify dysregulated immune networks in CVID patients with GI tract disorders, utilizing advanced techniques such as single cell RNA sequencing and high-dimensional flow cytometry.
Health CareHospitalMedical
Responsibilities
The main objective of my PhD project will be to identify dysregulated immune networks triggering and sustaining inflammation in CVID patients with GI tract disorders
My work will focus on the study of human gastrointestinal biopsies
I will use a combination of single cell RNA sequencing (scRNA-seq), high dimensional flow cytometry, and whole slide, high-resolution multiplex imagery approaches, to identify the functional alterations of immune cells within the CVID inflamed gut and/or stomach mucosa
The project will be structured around three specific aims (described in the following section “Goals/Outcomes of the Research Project”): 1) Investigating the cellular and molecular organizations of gut inflammatory lesions in CVID; 2) Addressing the role of B cells and autoantibodies in the pathogenesis of CVID gut inflammatory lesions; 3) Dissecting altered molecular trajectory of myeloid cells in CVID
Qualification
Required
PhD or MD
Company
Mount Sinai Health System
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
Founded in 2013
10001+ employees
H1B Sponsorship
Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageTotal Funding
$41.9MKey Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
Leadership Team
Vincent Tammaro
Executive Vice President and Chief Financial Officer
David Feinberg
Senior Vice President, Chief Marketing and Communications Officer
Recent News
Digital Journal
2026-01-08
Company data provided by crunchbase